Correction: Mol Neurodegener 18, 7 (2023)
https://doi.org/10.1186/s13024-023-00597-5
The original article [1] contained an obsolete version of Additional File 5: Fig. S5 which has since been amended.
Contributor Information
Kassandra Kisler, Email: kislerel@usc.edu.
Abhay P. Sagare, Email: Sagare@usc.edu
Divna Lazic, Email: divnalazic@yahoo.com.
Sam Bazzi, Email: sbazzi@utexas.edu.
Erica Lawson, Email: erica.lawson88@gmail.com.
Ching-Ju Hsu, Email: ching-ju.hsu@bcm.edu.
Yaoming Wang, Email: Yaomingw@usc.edu.
Anita Ramanathan, Email: anita.rrn@gmail.com.
Amy R. Nelson, Email: arnelson@southalabama.edu
Zhen Zhao, Email: zzhao@usc.edu.
Berislav V. Zlokovic, Email: zlokovic@usc.edu
Reference
- 1.Kisler K, et al. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier. Mol Neurodegener. 2023;18:7. doi: 10.1186/s13024-023-00597-5. [DOI] [PMC free article] [PubMed] [Google Scholar]